Colibricare Efficacy on Oral Surgical Procedures/Extraction Wound and Gingiva Retraction

Cairo University124 enrolled

Overview

In this randomized, three-arm trial, 120 patients undergoing wisdoms' extractions were assigned to control (gauze pressure application), commercial sponge, or Coli-sorb® groups. Outcomes included time to hemostasis, ease of placement, pain (VAS), facial swelling, and wound healing, assessed on days 1, 7, and 6 weeks.

Colisorb® is a safe, efficient, and biocompatible hemostatic agent, providing rapid bleeding control, reduced pain, and enhanced healing, outperforming conventional gauze and commercial alternatives.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

124

Conditions

Bleeding Pain

Interventions

wisdoms' surgical extractionsPROCEDURE

surgical removal of wisdoms

Eligibility

Sex: ALLMin age: 20 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * require wisdoms removal Exclusion Criteria: * systemic diseases affecting healing

Locations (1)

Cario University

Cairo, Cairo Governorate, Egypt

Outcomes

Primary Outcomes

pain

VAS visual analogue scale grades (0-10)

Time frame: 7 days

Secondary Outcomes

closure of the wound

binary method yes or no

Time frame: 15 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.